Published on in Vol 4, No 2 (2015): Apr-Jun
Journals
- Roy A, Brenneman R, Hogan J, Barnes J, Huang Y, Morris R, Goddu S, Altman M, Garcia-Ramirez J, Li H, Zoberi J, Bullock A, Kim E, Smith Z, Figenshau R, Andriole G, Baumann B, Michalski J, Gay H. Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis. Clinical and Translational Radiation Oncology 2021;29:47 View
- Winter R, Amghar M, Wacker A, Bakos G, Taş H, Roscher M, Kelly J, Benešová-Schäfer M. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy. Pharmaceuticals 2024;17(8):1031 View